TENX (STOCKS)
Tenax Therapeutics, Inc.
$14.500000
+0.075000 (+0.52%)
Prev close: $14.425000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Christopher T. Giordano
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $248.59M
- Employees
- 6
- P/E (TTM)
- -10.85
- P/B (TTM)
- 1.38
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.38 | $-0.42 | +0.0433 | +10.23% |
|
Sep 2025 (Q3)
|
$-0.40 | $-0.32 | -0.0812 | -25.47% |
|
Jun 2025 (Q2)
|
$-0.27 | $-0.24 | -0.0252 | -10.29% |
|
Mar 2025 (Q1)
|
$-0.28 | $-0.20 | -0.0828 | -41.99% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $56.39M |
| Research and Development | $32.67M |
| Other Operating Expenses | $23.71M |
| Operating Income/Loss | -$56.39M |
| Income/Loss From Continuing Operations After Tax | -$52.60M |
| Income/Loss From Continuing Operations Before Tax | -$52.60M |
| Income Tax Expense/Benefit | $0.00 |
| Interest Expense, Operating | $0.00 |
| Net Income/Loss | -$52.60M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$52.60M |
| Net Income/Loss Available To Common Stockholders, Basic | -$52.60M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.34 |
| Diluted Earnings Per Share | -$1.34 |
| Basic Average Shares | 39,217,244 |
| Diluted Average Shares | 39,217,244 |
| Assets | $104.23M |
| Current Assets | $104.23M |
| Prepaid Expenses | $5.64M |
| Other Current Assets | $98.58M |
| Noncurrent Assets | $0.00 |
| Liabilities | $7.16M |
| Current Liabilities | $7.16M |
| Accounts Payable | $6.04M |
| Wages | $898.00K |
| Other Current Liabilities | $217.00K |
| Noncurrent Liabilities | $0.00 |
| Equity | $97.07M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $97.07M |
| Liabilities And Equity | $104.23M |
| Net Cash Flow From Operating Activities | -$35.80M |
| Net Cash Flow From Operating Activities, Continuing | -$35.80M |
| Net Cash Flow From Investing Activities | -$2.71M |
| Net Cash Flow From Investing Activities, Continuing | -$2.71M |
| Net Cash Flow From Financing Activities | $38.51M |
| Net Cash Flow From Financing Activities, Continuing | $38.51M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$52.60M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$52.60M |
| Other Comprehensive Income/Loss | $0.00 |